Language
English
Publication Date
6-15-2026
Journal
Journal of Clinical Investigation
DOI
10.1172/JCI197651
PMID
42066052
PMCID
PMC13262735
PubMedCentral® Posted Date
4-30-2026
PubMedCentral® Full Text Version
Post-print
Abstract
Idiopathic pulmonary fibrosis (IPF) is a devastating chronic lung disorder with limited treatment options. Macropinocytosis is one of the key cellular processes involved in nutrient consumption from the extracellular environment under stress conditions. Here, we studied the role of macropinocytosis in experimental pulmonary fibrosis models. We found that macropinocytosis is increased in human lung fibroblasts (HLFs) derived from patients with IPF. The inhibition of macropinocytosis with 5-(n-ethyl-n-isopropyl)-amiloride (EIPA) inhibited profibrotic responses in IPF-derived and TGF-β1-stimulated HLFs and reduced pulmonary fibrosis in bleomycin-injured (Bleo-injured) mice. EIPA exerted its antifibrotic effects by regulating amino acid uptake, mammalian target of rapamycin complex 1 (mTORC1) activation and mesenchyme homeobox1 (MEOX1) expression in activated HLFs. Fittingly, genetic inhibition of macropinocytosis also ameliorated lung fibroblast activation and pulmonary fibrosis in mice. Using IPF-derived precision cut lung slices (PCLSs), we observed robust repression of profibrotic gene expression programs in EIPA-treated PCLSs across different fibroblast subpopulations. Finally, we found that imipramine (Imi), a tricyclic antidepressant approved by the FDA, effectively inhibited macropinocytosis and ameliorated profibrotic responses in lung fibroblasts, Bleo-injured mice, and IPF-derived PCLSs. Taken together, our results suggest that macropinocytosis inhibition can be considered as a potential therapeutic strategy to treat pulmonary fibrosis.
Keywords
Animals, Humans, Fibroblasts, Mice, Pinocytosis, Lung, Idiopathic Pulmonary Fibrosis, Disease Models, Animal, Amiloride, Bleomycin, Male, Transforming Growth Factor beta1, Mechanistic Target of Rapamycin Complex 1, Cell biology, Pulmonology, Fibrosis
Published Open-Access
yes
Recommended Citation
Rosas, Ivan O; McDowell-Sanchez, Aaron K; Sanchez, Santiago; et al., "Macropinocytosis Inhibition Attenuates Profibrotic Responses in Lung Fibroblasts and Pulmonary Fibrosis Models" (2026). Faculty, Staff and Students Publications. 6777.
https://digitalcommons.library.tmc.edu/baylor_docs/6777